ADAGENE INC-ADR Share Price Today: Live Updates & Key Insights
ADAGENE INC-ADR share price today is $3.6, up -1.63%. The stock opened at $3.66 against the previous close of $3.69, with an intraday high of $3.85 and low of $3.56.
ADAGENE INC-ADR Share Price Chart
ADAGENE INC-ADR
ADAGENE INC-ADR Share Price Performance
ADAGENE INC-ADR Institutional Holdings
ADAGENE INC-ADR Market Status
ADAGENE INC-ADR Fundamentals
Market Cap 84.84 M
PB Ratio 4.5128
PE Ratio 0.0
Enterprise Value 115.11 M
Total Assets 89.27 M
Volume 141428
ADAGENE INC-ADR Company Financials
About ADAGENE INC-ADR & investment objective
Company Information Adagene Inc., a clinical stage biotechnology company, engages in the research, development, and production of monoclonal antibody drugs for cancers in the People's Republic of China. Its lead product candidate is the ADG126, a masked fully-human anti-CTLA-4 mAb which is in phase 1b/2 clinical development for the treatment of cancer. The company also develops ADG116, a fully human anti-CTLA-4 antibody generated using NEObody technology, which is in phase 1b/2 clinical trials to treat advanced/metastatic solid tumors; ADG206, which is in phase 1 clinical development to treat advanced metastatic solid tumors; ADG104, anti-PD-L1 monoclonal antibody which is in phase 2 clinical development; and ADG125, a novel anti-CSF-1R mAb which is in Phase 2 clinical development. In addition, it is developing ADG138, a HER2xCD3 POWERbody which is in pre clinical trial to treat low expressing tumors, as well as resistant/refractory tumors; ADG152, a CD20xCD3 POWERbody which is in preclincal trial to treat off-tumor toxicities; ADG153, a masked anti-CD47 IgG1 SAFEbody, wihx is in preclinical trial for the treatment of hematologic and solid tumor; and CD28 T-cell engagers, an anti-CD28 bispecific POWERbody TCEs to treat solid tumors. The company was incorporated in 2011 and is headquartered in Suzhou, China.
Organisation Biotechnology
Employees 138
Industry Biotechnology
CEO Dr. Peter P. Luo Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
ADAGENE INC-ADR FAQs
What is the share price of ADAGENE INC-ADR today?
The current share price of ADAGENE INC-ADR is $3.6.
Can I buy ADAGENE INC-ADR shares in India?
Yes, Indian investors can buy ADAGENE INC-ADR shares by opening an international trading and demat account with Motilal Oswal.
How to buy ADAGENE INC-ADR shares in India?
You can easily invest in ADAGENE INC-ADR shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy ADAGENE INC-ADR shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of ADAGENE INC-ADR.
Can I buy fractional shares of ADAGENE INC-ADR?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of ADAGENE INC-ADR?
ADAGENE INC-ADR has a market cap of $84.84 M.
In which sector does ADAGENE INC-ADR belong?
ADAGENE INC-ADR operates in the Biotechnology sector.
What documents are required to invest in ADAGENE INC-ADR stocks?
To invest, you typically need:
What is the PE and PB ratio of ADAGENE INC-ADR?
The PE ratio of ADAGENE INC-ADR is N/A and the PB ratio is 4.51.